NanoViricides Inc. (NNVC)

[JG36]

And, now you know that even $13,000 is too much.

Actually, I don't know that. That study gave $15,000 as the average per patient cost of phase 3 trials in the fields of rheumatology and analgesia. How expensive can it be to give someone with aches and pains a pill and then ask him a couple of weeks later if he hurts less? I doubt that testing a flu drug is going to be a whole lot cheaper.